The metabolically healthy overweight and obese and their impact on all-cause mortality

Obesity

Volumn 21, Issue 9, 2013, Pages 1750-1752

  Loos, Ruth J F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1;

ADIPOGENESIS; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; GENETIC ASSOCIATION; HUMAN; IRS1 GENE; MORTALITY; OBESITY; PHYSICAL ACTIVITY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

BODY MASS INDEX; BODY WEIGHT; CAUSE OF DEATH; HUMANS; OBESITY; OVERWEIGHT;

EID: 84884830802     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20601     Document Type: Article

References (15)

1. Willett WC, Dietz WH, Colditz GA,. Guidelines for healthy weight. N Engl J Med 1999; 341: 427-434.
2. Flegal KM, Kit BK, Orpana H, Graubard BI,. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82.
3. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
4. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S,. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007; 100: 1654-1658.
5. Bradshaw PT, Monda KL, Stevens J,. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study. Obesity (Silver Spring) 2013; 21: 203-209.
6. Hamer M, Stamatakis E,. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
7. Wildman RP, Mcginn AP, Lin J, et al. Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring) 2011; 19: 853-860.
8. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215.
9. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
10. Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 2007; 3: e64.
11. Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105: 271-278.
12. Mclaughlin T, Deng A, Yee G, et al. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 2010; 53: 369-377.
13. Kilpelainen TO, Zillikens MC, Stancakova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011; 43: 753-760.
14. Arnlov J, Sundstrom J, Ingelsson E, Lind L,. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011; 34: 61-65.
15. Kuk JL, Ardern CI,. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009; 32: 2297-2299.